Raymond James Financial Inc. Acquires New Shares in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Raymond James Financial Inc. acquired a new position in Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 119,261 shares of the company's stock, valued at approximately $5,494,000. Raymond James Financial Inc. owned about 0.43% of Establishment Labs as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the stock. R Squared Ltd bought a new position in shares of Establishment Labs during the fourth quarter valued at about $36,000. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Establishment Labs during the 3rd quarter worth approximately $127,000. Handelsbanken Fonder AB boosted its stake in shares of Establishment Labs by 32.3% in the 4th quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company's stock worth $378,000 after buying an additional 2,000 shares during the last quarter. Verition Fund Management LLC grew its holdings in shares of Establishment Labs by 22.8% in the third quarter. Verition Fund Management LLC now owns 9,400 shares of the company's stock valued at $407,000 after acquiring an additional 1,746 shares in the last quarter. Finally, Maven Securities LTD purchased a new stake in shares of Establishment Labs during the third quarter valued at approximately $433,000. Institutional investors own 72.91% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Stephens reissued an "overweight" rating and issued a $52.00 price objective on shares of Establishment Labs in a research report on Thursday, March 6th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $57.40.

Establishment Labs Stock Performance

Shares of Establishment Labs stock traded down $0.21 on Friday, reaching $40.43. 250,123 shares of the company traded hands, compared to its average volume of 425,061. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29. The firm has a market capitalization of $1.17 billion, a PE ratio of -15.67 and a beta of 0.95. The company has a 50 day moving average of $36.24 and a 200 day moving average of $40.84. Establishment Labs Holdings Inc. has a 52 week low of $28.16 and a 52 week high of $60.12.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The company reported ($0.98) earnings per share for the quarter, missing the consensus estimate of ($0.64) by ($0.34). Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. The firm had revenue of $44.51 million for the quarter, compared to the consensus estimate of $44.45 million. Equities analysts forecast that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current year.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.